Bafna Pharmaceuticals reports standalone net loss of Rs 3.75 crore in the September 2016 quarter

Sales rise 3.13% to Rs 16.49 crore

Net Loss of Bafna Pharmaceuticals reported to Rs 3.75 crore in the quarter ended September 2016 as against net loss of Rs 2.41 crore during the previous quarter ended September 2015. Sales rose 3.13% to Rs 16.49 crore in the quarter ended September 2016 as against Rs 15.99 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales16.4915.99 3 OPM %1.218.76 -PBDT-2.78-1.64 -70 PBT-3.80-2.17 -75 NP-3.75-2.41 -56

Powered by Capital Market - Live News